Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/09/2010US20100311741 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents
12/09/2010US20100311739 Naphthalene Diimide Compounds
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311733 Thiadiazinone derivatives
12/09/2010US20100311732 Novel heterocyclic compounds
12/09/2010US20100311730 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use
12/09/2010US20100311721 Compounds
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100311714 1H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS
12/09/2010US20100311712 Modulators of cxcr7
12/09/2010US20100311709 2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA [f]INDAZOLE-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
12/09/2010US20100311695 Hydroxy-bisphosphonic acid derivatives as vector targeting bone tissue
12/09/2010US20100311693 Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives
12/09/2010US20100311689 Combination therapy with organic arsenicals
12/09/2010US20100311679 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
12/09/2010US20100311678 Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
12/09/2010US20100311669 Compounds that bind to p185 and methods of using the same
12/09/2010US20100311652 Genetic marker for use in the treatment of leukemia
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311640 Self-assembling peptide incorporating modifications and methods of use thereof
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100311105 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/09/2010US20100311050 Compositions and methods for the diagnosis and treatment of tumor
12/09/2010US20100311045 Cancer
12/09/2010US20100310690 Pharmaceutical product and analysis model for hormone replacement therapy for women and prevention of some cancers and uterine myomas
12/09/2010US20100310677 Stable amorphous calcium carbonate comprising phosphorylated amino acids
12/09/2010US20100310675 Aminopyrimidines useful as kinase inhibitors
12/09/2010US20100310674 Novel composition for treating the side effects of anticancer treatments
12/09/2010US20100310668 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
12/09/2010US20100310661 Oral formulations for picoplatin
12/09/2010US20100310651 Solid pharmaceutical compositions and processes for their production
12/09/2010US20100310648 Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor
12/09/2010US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4
12/09/2010US20100310645 Methods for inhibiting tumor cell proliferation
12/09/2010US20100310643 Cd133 epitopes
12/09/2010US20100310640 Hla-dr binding peptides and their uses
12/09/2010US20100310612 Medicament for the Treatment of Cancer of the Pancreas
12/09/2010US20100310603 TEM8 as an Adjuvant and Uses Thereof
12/09/2010US20100310600 Selective agonist of toll-like receptor 3
12/09/2010US20100310596 Method and Compositions for Cutaneous Immunisation
12/09/2010US20100310594 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
12/09/2010US20100310585 The use of monomycolyl glycerol (mmg) as an adjuvant
12/09/2010US20100310583 Let-7 microrna and mimetics thereof as therapeutics for cancer
12/09/2010US20100310581 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
12/09/2010US20100310579 Method for inhibiting angiogenesis or for treatment of cancer
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310573 Anti-cd4 antibody
12/09/2010US20100310571 Uses of monoclonal antibody 8h9
12/09/2010US20100310567 Antibodies Against Human CCN1 and Uses Thereof
12/09/2010US20100310563 Methods for treating induced cellular proliferative disorders
12/09/2010US20100310562 System for delivery into xcr1 positive cell and uses thereof
12/09/2010US20100310559 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
12/09/2010US20100310557 Antibodies immunoreactive with heregulin-coupled her3
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310554 Methods for Reversing Multiple Resistance in Animal Cells
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310537 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310536 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310535 Method for expanding hematopoietic stem cells using heterocyclic compound
12/09/2010US20100310534 T cell subpopulations capable of treating cancer
12/09/2010US20100310528 Vector System for Site-Specific Integration
12/09/2010US20100310519 Incorporation of Active Molecules into Microalga
12/09/2010US20100310516 Duplexed Parvovirus Vectors
12/09/2010US20100310515 Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site
12/09/2010US20100310514 Anti-Inflammatory Bacteria
12/09/2010US20100310513 Bifidobacterial species
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
12/09/2010US20100310507 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/09/2010US20100310506 Immunoconjugates for the Treatment of Tumours
12/09/2010US20100310505 Methods of treating cancer using il-21
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100310497 Pharmaceutical composition or combination drug
12/09/2010US20100310482 3-Deoxyglucosone And Skin
12/09/2010US20100310474 Protein cages for the delivery of medical imaging and therapeutic agents
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310469 Vaccine immunotherapy for immune suppressed patients
12/09/2010US20100310466 Thienopyranones as kinase inhibitors
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310464 Antibodies
12/09/2010US20100310463 Anti-EpCAM Antibodies
12/09/2010US20100310458 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010US20100310454 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpart
12/09/2010US20100310453 Heterologous antibodies which bind human cd4
12/09/2010US20100310452 Prostate-specific membrane antigen and uses thereof
12/09/2010DE102009024296A1 New 1-(4-chloro-3-trifluoromethyl-phenyl)-3-(4-(pyridin-4-yloxy)-phen yl)-urea compounds useful to treat e.g. cancer, asthma, urticaria, arthritis, osteoarthritis, rheumatoid arthritis, sepsis, autoimmune diseases and multiple sclerosis
12/09/2010CA2764499A1 Interlaced method for treating cancer or a precancerous condition
12/09/2010CA2764480A1 Therapeutic and diagnostic molecules
12/09/2010CA2764449A1 Nucleic acid modulators of glycoprotein vi
12/09/2010CA2764445A1 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010CA2764339A1 Azole derivatives as wtn pathway inhibitors
12/09/2010CA2764234A1 Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(adp-ribose) polymerase and uses thereof
12/09/2010CA2764230A1 Proteins modified with (amino)-monosaccharide-biotin adduct
12/09/2010CA2763822A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010CA2763821A1 1h-imidazo[4,5-c]quinolinone derivatives
12/09/2010CA2763040A1 Methods and compositions for the treatment of cancer
1 ... 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 ... 2211